Postes actifs de Oliver Middendorp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Numab Therapeutics AG
 Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Directeur/Membre du Conseil | 01/01/2011 | - |
| Fondateur | 01/01/2011 | - | |
| Corporate Officer/Principal | 01/01/2011 | - |
Historique de carrière de Oliver Middendorp
Statistiques
Internationale
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Numab Therapeutics AG
Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Commercial Services |
- Bourse
- Insiders
- Oliver Middendorp
- Expérience
